[Combination therapy with biguanides].
作者信息
Sakura Hiroshi
机构信息
Diabetes Center, Tokyo Women's Medical University.
出版信息
Nihon Rinsho. 2002 Oct;60 Suppl 10:724-8.
PMID:12430309
Abstract
摘要
相似文献
1
[Combination therapy with biguanides].
Nihon Rinsho. 2002 Oct;60 Suppl 10:724-8.
2
[Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Nihon Rinsho. 2002 Sep;60 Suppl 9:464-9.
3
Pharmacological treatment of type 2 diabetes.
Acta Clin Belg. 2004 Mar-Apr;59(2):59-66. doi: 10.1179/acb.2004.008.
4
The use of insulin alone and in combination with oral agents in type 2 diabetes.
Prim Care. 1999 Dec;26(4):931-50. doi: 10.1016/s0095-4543(05)70140-8.
5
Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.
Diabetes Obes Metab. 2000 Jun;2(3):139-47. doi: 10.1046/j.1463-1326.2000.00054.x.
6
Targeted glycemic control in type 2 diabetes.
J Fla Med Assoc. 1998 Aug;85(2):7-15.
7
Oral combination therapy for type 2 diabetes.
Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S70-6. doi: 10.1002/dmrr.278.
8
International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
Diabetes Care. 1998 Jun;21(6):1024-6. doi: 10.2337/diacare.21.6.1024.
9
The use of insulin secretagogues in the treatment of type 2 diabetes.
Prim Care. 1999 Dec;26(4):895-915. doi: 10.1016/s0095-4543(05)70138-x.
10
Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
Arch Intern Med. 1997 Apr 28;157(8):836-48.
Zotero 插件